Mark Cuban Cost Plus Drugs review: is it worth it?

What is Cost Plus Drugs and how does it actually work?

Cost Plus Drugs is the consumer-facing online pharmacy of the Mark Cuban Cost Plus Drug Company (MCCPDC), co-founded by entrepreneur Mark Cuban and physician Alex Oshmyansky and launched in January 2022. Its premise is unusually simple for U.S. healthcare: instead of the opaque, rebate-driven pricing that flows through pharmacy benefit managers (PBMs), the company publishes what it pays for each drug and adds a small, disclosed margin on top. Since launch it has grown to carry well over 2,000 prescription products, and it has built its own pharmaceutical manufacturing facility in Dallas, Texas — which became operational in 2023, with in-house production of certain medications beginning in 2024.

The practical flow is straightforward:

1. Get a prescription to MCCPDC. Cost Plus Drugs is a real pharmacy, so it can only dispense with a valid prescription. Your prescriber can e-prescribe directly to the pharmacy, or you can ask Cost Plus to transfer an existing prescription from your current pharmacy. Transfers typically take a day or two.
2. See the full price breakdown before you buy. This is the differentiator. For every drug the site shows the manufacturer/acquisition cost, the markup, the pharmacy labor fee, and shipping — itemized — so you know exactly why the price is what it is.
3. Pay cash. There is no insurance billing. You pay the listed total directly.
4. It ships to your door. Orders are filled by accredited pharmacy facilities and mailed nationwide. There is no physical storefront and no in-person pickup.

It's worth separating the parts of the company. The thing most consumers use is the online cash-pay pharmacy. Separately, MCCPDC also operates as a drug wholesaler/manufacturer and has built PBM and employer-facing programs (e.g., transparent "cost-plus" pricing arrangements for self-insured employers and partnerships with other pharmacies and plans). This review focuses on the consumer online pharmacy, since that is what an individual shopper actually interacts with.

Is Cost Plus Drugs legitimate and safe?

Yes — it meets the credentials that distinguish a legitimate online pharmacy from a rogue one. The FDA's BeSafeRx campaign tells consumers to verify three things before using any online pharmacy: it requires a valid prescription, it is licensed by a U.S. state board of pharmacy, and it has a licensed pharmacist available (FDA). Cost Plus Drugs passes all three. It requires a prescription, it dispenses through licensed and accredited pharmacy facilities, and prescriptions are reviewed by licensed pharmacists. Its dispensing operations carry pharmacy accreditation (including URAC mail-service accreditation), and the company is appropriately licensed to ship across state lines.

The inverse pattern is what marks an illegitimate site: no prescription needed, no U.S. license, no identifiable pharmacist, and prices that are implausibly low with no transparency about who is dispensing. Cost Plus Drugs fails none of those tests — and unusually, its entire pitch is built on showing you the cost math rather than hiding it.

A few honest caveats that are operational rather than regulatory:

• It is mail-order only. If you need a medication today, a local pharmacy will serve you faster.
• Because it is cash-pay and uses a fixed-fee structure, very inexpensive drugs can occasionally be *more* expensive than a $4 retail generic once the labor fee and shipping are added. The savings are real but not universal — you have to check the specific drug.

What does Cost Plus Drugs cost, and how does the pricing model work?

This is the heart of the product. Every price is built from disclosed components rather than a negotiated, hidden number:

• Acquisition cost — what MCCPDC actually pays for the drug.
• A fixed 15% markup — the company's margin, applied uniformly rather than varying drug-to-drug.
• A flat pharmacy labor fee — a small per-prescription dispensing fee (commonly cited around $3).
• A flat shipping fee — typically around $5 per order, regardless of how many medications are in it.

Because the markup is a fixed percentage and the fees are flat, the model is most powerful on drugs where the *true* acquisition cost is far below what the traditional supply chain charges. Many specialty and chronic-disease generics have historically been marked up enormously somewhere between manufacturer and patient; stripping that out is where the dramatic savings come from. For a cheap, already-commoditized generic, the flat fees can make Cost Plus a wash or slightly worse — which is exactly why the company's price transparency is useful: you can do the comparison yourself.

What it is not: there is no membership or subscription required to buy at the listed prices (unlike some competing programs). You simply pay the transparent total per order. Batching multiple prescriptions into one shipment spreads the single shipping fee across more drugs.

Does Cost Plus Drugs accept insurance?

No — and this is the single most important thing to understand. Cost Plus Drugs does not bill insurance, Medicare, or Medicaid. Every purchase is cash-pay. In some cases you can submit your receipt to your insurer for possible out-of-network reimbursement, but whether that works depends entirely on your plan, and many plans will not reimburse mail-order cash purchases.

There is also a coverage consequence many people miss: because it's cash-pay, amounts you spend at Cost Plus generally do not count toward your insurance deductible or out-of-pocket maximum, and for Medicare beneficiaries they do not count toward Part D's out-of-pocket spending. For someone with a low copay or who is racing toward a deductible, running prescriptions through insurance may still be the better long-run move even when the cash price looks higher. The right answer is genuinely case-by-case — which makes Cost Plus a price-comparison tool first.

How much can it actually save you? What the evidence shows

The savings claims here are unusually well studied for a consumer health product, because researchers have been able to compare MCCPDC's transparent list prices against public Medicare data.

• In a widely cited analysis in Annals of Internal Medicine (2022, PMID 35724381), researchers estimated that Medicare could have saved up to roughly $3.6 billion in a single year — about 37% of spending — on a set of generic drugs had it purchased them at MCCPDC prices instead of the prices it actually paid. Crucially, the savings were not universal: of the 77 generics analyzed, most — but not all — were cheaper at Cost Plus, underscoring that you must check drug by drug.
• A Journal of Clinical Oncology (2023, PMID 37290029) analysis of seven generic oncology drugs estimated potential Medicare savings of roughly $661.8 million (about 79%), with per-patient annual savings reaching into the tens of thousands of dollars for high-cost generics like abiraterone (about $25,000/year) and imatinib (roughly $17,500–$20,500/year).
• Additional peer-reviewed work (e.g., in *The Oncologist*, 2024) has likewise found large potential savings for specific generic categories, while consistently noting the same limitation: results depend heavily on which drug you need.

A separate body of analysis comparing Cost Plus against commercial-insurance copays has found that for many generic prescriptions the cash price beats the insured copay a large share of the time — frequently when a copay or coinsurance climbs above roughly $15. The honest summary: for the right generics, the savings are large and well documented; for cheap commodity generics, the advantage shrinks or disappears.

What medications are available — and what isn't?

Cost Plus Drugs stocks commonly prescribed generic medications plus a growing list of brand-name and specialty drugs, but it is not a full-line pharmacy and its formulary is deliberately curated. Strengths and limits:

Strong fit:

• High-volume chronic-disease generics — blood pressure, cholesterol, type 2 diabetes (oral), thyroid, mental health, and many others.
• Certain high-cost specialty generics where the traditional markup has been extreme. The company has expanded into specialty and biosimilar products over time.

Not available / weaker fit:

• Controlled substances are not dispensed. That rules out most opioids, ADHD stimulants like Adderall, many anxiety benzodiazepines, and similar Schedule II–IV drugs — a category limit it shares with several mail-order competitors.
• Refrigerated/short-stability and certain acute medications can be impractical for mail order.
• Anything you need same-day — there's no local pickup.
• Patients under 18 generally cannot be served directly.

Because the catalog changes, the only reliable approach is to search the specific drug and strength you need on the site and compare the transparent total to your other options.

Who is Cost Plus Drugs best for — and who should skip it?

Best for:

• People who pay cash for prescriptions, are uninsured, or are underinsured with a high deductible.
• Anyone on an expensive generic — especially specialty generics — where the traditional supply-chain markup is steep.
• People comfortable with mail order and planning refills ahead of time.
• Anyone who simply wants to price-check: even if you ultimately use insurance, the transparent number is a useful benchmark.

Should think twice:

• People who need controlled substances (not available) or same-day medication.
• Anyone whose insurance gives a very low copay, or who needs the spend to count toward a deductible or out-of-pocket max.
• Patients on cheap commodity generics already available for a few dollars at retail, where flat fees can erase the advantage.

How does it compare to GoodRx, Amazon Pharmacy, and insurance?

These tools solve overlapping but different problems, and the smartest consumers use more than one:

• vs. GoodRx: GoodRx is a discount-coupon *aggregator* accepted at tens of thousands of retail pharmacies — broad drug coverage (including many it can discount that Cost Plus doesn't stock) and instant in-store pickup, but prices fluctuate by pharmacy and aren't transparently itemized. Cost Plus offers a *fixed, transparent* price and is mail-only with a narrower formulary. For an expensive generic on the Cost Plus list, Cost Plus often wins; for breadth, immediacy, or a drug Cost Plus doesn't carry, GoodRx is more flexible.
• vs. Amazon Pharmacy: Amazon Pharmacy *does* accept insurance and offers a Prime cash price plus the $5/month RxPass subscription, with fast Prime delivery and a broader catalog. Cost Plus carries no subscription and no insurance billing but a uniquely transparent cost-plus price that can undercut Amazon on certain specialty generics.
• vs. your insurance: For low copays or deductible-relevant spending, insurance frequently still wins on net. Cost Plus shines when your insured price is high or when you're paying cash anyway.

The practical takeaway: price-check the exact drug across Cost Plus, your insurance copay, and a coupon tool before every fill — the cheapest channel genuinely varies by medication.

The bottom line

Mark Cuban Cost Plus Drugs is a legitimate, licensed, cash-pay mail-order pharmacy whose defining feature — full price transparency with a fixed 15% markup plus flat fees — is exactly what the rest of U.S. drug pricing lacks. Peer-reviewed analyses (Annals of Internal Medicine 2022, J Clin Oncol 2023) confirm that the savings on many generics, especially high-cost specialty generics, are large and real. But the model has clear edges: no insurance billing, no controlled substances, no same-day pickup, a curated formulary, and flat fees that can erase the advantage on cheap commodity drugs. Treat it as a high-value tool to compare against your insurance copay and coupon options on a drug-by-drug basis — for the right prescriptions it is one of the best deals in American pharmacy, and either way the transparent price is a benchmark worth knowing.